The Co-Expression of Programmed Death-Ligand 1 (PD-L1) in Untreated EGFR-Mutated Metastatic Lung Adenocarcinoma

Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) is the standard first-line therapy for metastatic lung adenocarcinoma harboring sensitive EGFR mutations. Tumor surface programmed death-ligand 1 (PD-L1) is expressed in some metastatic EGFR-mutated lung adenocarcinoma, but its...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biomedicines
Autors principals: Hsu, Ping-Chih, Wang, Chih-Wei, Kuo, Scott Chih-Hsi, Lin, Shu-Min, Lo, Yu-Lun, Huang, Allen Chung-Cheng, Chiu, Li-Chung, Yang, Cheng-Ta
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7167989/
https://ncbi.nlm.nih.gov/pubmed/32092879
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines8020036
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars